Perceived physical health outcomes of direct-acting antiviral treatment for hepatitis C: a qualitative study
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1477-7517
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Perceived physical health outcomes of direct-acting antiviral treatment for hepatitis C: a qualitative study ; volume:18 ; number:1 ; day:15 ; month:7 ; year:2021 ; pages:1-6 ; date:12.2021
Harm reduction journal ; 18, Heft 1 (15.7.2021), 1-6, 12.2021
- Creator
-
Goutzamanis, Stelliana
Horyniak, Danielle
Doyle, Joseph S.
Hellard, Margaret
Higgs, Peter
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12954-021-00516-1
- URN
-
urn:nbn:de:101:1-2021101723514576285653
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:35 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Goutzamanis, Stelliana
- Horyniak, Danielle
- Doyle, Joseph S.
- Hellard, Margaret
- Higgs, Peter
- SpringerLink (Online service)
Other Objects (12)
Direct-Acting Antiviral Therapy for Hepatitis C: Attitudes Regarding Future Use
Direct-acting antiviral resistance of Hepatitis C virus is promoted by epistasis
Adoption of direct-acting antiviral medications for hepatitis C: a retrospective observational study
Outcome of direct-acting antiviral treatment in patients with hepatitis C virus/hepatitis B virus coinfection
Acute reversible rhabdomyolysis during direct-acting antiviral hepatitis C virus treatment: a case report
Direct-acting antiviral treatment downregulates immune checkpoint inhibitor expression in patients with chronic hepatitis C
Hepatitis C in healthcare personnel: secondary data analysis of therapies with direct-acting antiviral agents
Hepatitis C in healthcare personnel: follow-up analysis of treatments with direct-acting antiviral agents
The role of a hepatitis C virus vaccine: modelling the benefits alongside direct-acting antiviral treatments
Regression in hepatic fibrosis in elderly Chinese patients with hepatitis C receiving direct-acting antiviral treatment
Effect of immunogenetics polymorphism and expression on direct-acting antiviral drug response in chronic hepatitis C
Correlation of host factor with virological response to direct-acting antiviral treatment in hepatitis C patients
Direct-Acting Antiviral Therapy for Hepatitis C: Attitudes Regarding Future Use
Direct-acting antiviral resistance of Hepatitis C virus is promoted by epistasis
Adoption of direct-acting antiviral medications for hepatitis C: a retrospective observational study
Outcome of direct-acting antiviral treatment in patients with hepatitis C virus/hepatitis B virus coinfection
Acute reversible rhabdomyolysis during direct-acting antiviral hepatitis C virus treatment: a case report
Direct-acting antiviral treatment downregulates immune checkpoint inhibitor expression in patients with chronic hepatitis C
Hepatitis C in healthcare personnel: secondary data analysis of therapies with direct-acting antiviral agents
Hepatitis C in healthcare personnel: follow-up analysis of treatments with direct-acting antiviral agents
The role of a hepatitis C virus vaccine: modelling the benefits alongside direct-acting antiviral treatments
Regression in hepatic fibrosis in elderly Chinese patients with hepatitis C receiving direct-acting antiviral treatment
Effect of immunogenetics polymorphism and expression on direct-acting antiviral drug response in chronic hepatitis C
Correlation of host factor with virological response to direct-acting antiviral treatment in hepatitis C patients
Direct-Acting Antiviral Therapy for Hepatitis C: Attitudes Regarding Future Use
Direct-acting antiviral resistance of Hepatitis C virus is promoted by epistasis
Adoption of direct-acting antiviral medications for hepatitis C: a retrospective observational study
Outcome of direct-acting antiviral treatment in patients with hepatitis C virus/hepatitis B virus coinfection
Acute reversible rhabdomyolysis during direct-acting antiviral hepatitis C virus treatment: a case report
Direct-acting antiviral treatment downregulates immune checkpoint inhibitor expression in patients with chronic hepatitis C
Hepatitis C in healthcare personnel: secondary data analysis of therapies with direct-acting antiviral agents
Hepatitis C in healthcare personnel: follow-up analysis of treatments with direct-acting antiviral agents
The role of a hepatitis C virus vaccine: modelling the benefits alongside direct-acting antiviral treatments
Regression in hepatic fibrosis in elderly Chinese patients with hepatitis C receiving direct-acting antiviral treatment
Effect of immunogenetics polymorphism and expression on direct-acting antiviral drug response in chronic hepatitis C